Comprehensive NeuroScience Announces New Company Name

Published on: 

Company News Release

Comprehensive NeuroScience

is pleased to announce its plans to roll out the new company name,

Comprehensive Clinical Development


. Under its new name, Comprehensive Clinical Development will continue to deliver CRO services in partnership with quality sponsors.

Comprehensive Clinical Development offers full-service capabilities and therapeutic expertise in numerous indications, including, but not limited to, CNS, dermatology, diabetes, infectious disease, obesity, and postmenopausal women, and collects early efficacy data across these populations.

Offering CRO services both of developmental and clinical conduct, Comprehensive Clinical Development leverages the diversity of its service networks to provide biopharmaceutical clients with exceptional quality and cost-effective trial management. Along with early and late phase site clinical conduct, Comprehensive Clinical Development provides a full range of services from protocol writing through final clinical study reporting.